BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

76 related articles for article (PubMed ID: 11299471)

  • 1. [Variables associated with cognitive deterioration in Parkinson's disease].
    Sánchez Rodríguez JL; Sayago Arenas AM
    Rev Neurol; 2001 Jan 16-31; 32(2):107-11. PubMed ID: 11299471
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Evaluation of cognitive impairment in a population of patients with Parkinson's disease by means of the mini mental Parkinson test].
    Parrao-Díaz T; Chaná-Cuevas P; Juri-Claverías C; Kunstmann C; Tapia-Núñez J
    Rev Neurol; 2005 Mar 16-31; 40(6):339-44. PubMed ID: 15795869
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Cognition deterioration in Parkinson's disease: associated risk factors].
    Errea JM; Ara JR
    Rev Neurol; 1999 Mar 1-15; 28(5):439-43. PubMed ID: 10229953
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Cognitive deterioration in Parkinson's disease].
    Perea-Bartolomé MV
    Rev Neurol; 2001 Jun 16-30; 32(12):1182-7. PubMed ID: 11562851
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical spectrum of Parkinson's disease from Pakistan.
    Khealani BA; Baig SM
    Singapore Med J; 2006 Dec; 47(12):1075-9. PubMed ID: 17139405
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Relationship between clinical phenotypes and cognitive impairment in Parkinson's disease (PD).
    Oh JY; Kim YS; Choi BH; Sohn EH; Lee AY
    Arch Gerontol Geriatr; 2009; 49(3):351-4. PubMed ID: 19136159
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Dementia in Parkinson's disease].
    Halvorsen Ø; Tysnes OB
    Tidsskr Nor Laegeforen; 2007 Oct; 127(19):2517-20. PubMed ID: 17925819
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The association between motor subtypes and psychopathology in Parkinson's disease.
    Reijnders JS; Ehrt U; Lousberg R; Aarsland D; Leentjens AF
    Parkinsonism Relat Disord; 2009 Jun; 15(5):379-82. PubMed ID: 18977165
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Cognitive deterioration in Parkinson's disease].
    Vilert Barnet J; Jarne Esparcia A; Aguilar Barbera M
    Arch Neurobiol (Madr); 1991; 54(6):311-7. PubMed ID: 1811462
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The relation between cognition and motor dysfunction in drug-naive newly diagnosed patients with Parkinson's disease.
    Domellöf ME; Elgh E; Forsgren L
    Mov Disord; 2011 Oct; 26(12):2183-9. PubMed ID: 21661051
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Dementia and cognitive impairment in Parkinson disease].
    Gershanik OS
    Vertex; 2002; 13(49):184-8. PubMed ID: 12404019
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cognitive status correlates with neuropathologic stage in Parkinson disease.
    Braak H; Rüb U; Jansen Steur EN; Del Tredici K; de Vos RA
    Neurology; 2005 Apr; 64(8):1404-10. PubMed ID: 15851731
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Laterality, region, and type of motor dysfunction correlate with cognitive impairment in Parkinson's disease.
    Williams LN; Seignourel P; Crucian GP; Okun MS; Rodriguez RL; Skidmore FM; Foster PS; Jacobson CE; Romrell J; Bowers D; Fernandez HH
    Mov Disord; 2007 Jan; 22(1):141-5. PubMed ID: 17089386
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cognitive decline in early Parkinson's disease.
    Kandiah N; Narasimhalu K; Lau PN; Seah SH; Au WL; Tan LC
    Mov Disord; 2009 Mar; 24(4):605-8. PubMed ID: 19191342
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Side and type of motor symptom influence cognition in Parkinson's disease.
    Katzen HL; Levin BE; Weiner W
    Mov Disord; 2006 Nov; 21(11):1947-53. PubMed ID: 16991155
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Psychoses in patients with Parkinson's disease; their frequency, phenomenology, and clinical correlates].
    Kashihara K; Ohno M; Katsu Y
    Rinsho Shinkeigaku; 2005 Jan; 45(1):1-5. PubMed ID: 15714992
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Neuropsychological characteristics of Parkinson's disease].
    Ostrosky-Solis F
    Rev Neurol; 2000 Apr 16-30; 30(8):788-96. PubMed ID: 10893746
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The rate of cognitive decline in Parkinson disease.
    Aarsland D; Andersen K; Larsen JP; Perry R; Wentzel-Larsen T; Lolk A; Kragh-Sørensen P
    Arch Neurol; 2004 Dec; 61(12):1906-11. PubMed ID: 15596611
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Changes in motor subtype and risk for incident dementia in Parkinson's disease.
    Alves G; Larsen JP; Emre M; Wentzel-Larsen T; Aarsland D
    Mov Disord; 2006 Aug; 21(8):1123-30. PubMed ID: 16637023
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cognitive impairment in Parkinson's disease: tools for diagnosis and assessment.
    Kulisevsky J; Pagonabarraga J
    Mov Disord; 2009 Jun; 24(8):1103-10. PubMed ID: 19353727
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.